{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:55:49Z","timestamp":1793386549974,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Chen Xiaoping Science and Technology Development Foundation of Hubei","award":["CXPJJH125004-039"],"award-info":[{"award-number":["CXPJJH125004-039"]}]},{"name":"Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine","award":["20261452"],"award-info":[{"award-number":["20261452"]}]},{"name":"Foundation of High level construction of traditional Chinese medicine","award":["SG2024012"],"award-info":[{"award-number":["SG2024012"]}]},{"name":"Foundation of Guangdong Provincial \"14th Five Year Plan\" Key Specialty of Traditional Chinese Medicine and Municipal Advantageous Specialty of Traditional Chinese Medicine","award":["X33010103708"],"award-info":[{"award-number":["X33010103708"]}]},{"name":"Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center","award":["GWJJMB202510022151"],"award-info":[{"award-number":["GWJJMB202510022151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11690-5","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:37:55Z","timestamp":1774438675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repression of FOSL1 augments ferroptosis to overcome oxaliplatin resistance in colorectal cancer by acting on SRSF2"],"prefix":"10.1007","volume":"53","author":[{"given":"Bo","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"3","key":"11690_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"10449","key":"11690_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","volume":"404","author":"C Eng","year":"2024","unstructured":"Eng C et al (2024) Colorectal cancer. Lancet 404(10449):294\u2013310","journal-title":"Lancet"},{"issue":"1","key":"11690_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.drudis.2021.09.012","volume":"27","author":"D Duarte","year":"2022","unstructured":"Duarte D, Vale N (2022) Combining repurposed drugs to treat colorectal cancer. Drug Discov Today 27(1):165\u2013184","journal-title":"Drug Discov Today"},{"key":"11690_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60121951","author":"W Shalata","year":"2024","unstructured":"Shalata W et al (2024) Colorectal cancer in elderly patients: insights into presentations, prognosis, and patient outcomes. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina60121951","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"11690_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12885-023-10941-z","volume":"23","author":"S Abe","year":"2023","unstructured":"Abe S et al (2023) Preoperative chemoradiotherapy using tegafur\/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial. BMC Cancer 23(1):450","journal-title":"BMC Cancer"},{"issue":"1","key":"11690_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-022-00902-6","volume":"7","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Downregulation of MEIS1 mediated by ELFN1-AS1\/EZH2\/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. Signal Transduct Target Ther 7(1):87","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"11690_CR7","doi-asserted-by":"publisher","first-page":"e21400","DOI":"10.1016\/j.heliyon.2023.e21400","volume":"9","author":"S Abdulzehra","year":"2023","unstructured":"Abdulzehra S, Jafari-Gharabaghlou D, Zarghami N (2023) Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells. Heliyon 9(11):e21400","journal-title":"Heliyon"},{"issue":"1","key":"11690_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21(1):47","journal-title":"Mol Cancer"},{"issue":"22","key":"11690_CR9","doi-asserted-by":"publisher","first-page":"e2100997","DOI":"10.1002\/advs.202100997","volume":"8","author":"X Yao","year":"2021","unstructured":"Yao X et al (2021) Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells. Adv Sci (Weinh) 8(22):e2100997","journal-title":"Adv Sci (Weinh)"},{"issue":"25","key":"11690_CR10","doi-asserted-by":"publisher","first-page":"e2301088","DOI":"10.1002\/advs.202301088","volume":"10","author":"K Zeng","year":"2023","unstructured":"Zeng K et al (2023) Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer. Adv Sci (Weinh) 10(25):e2301088","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"11690_CR11","doi-asserted-by":"publisher","first-page":"152394","DOI":"10.1016\/j.prp.2019.03.022","volume":"215","author":"X Zhu","year":"2019","unstructured":"Zhu X et al (2019) Expression and clinical significance of FOS-like antigen 1 in gastric adenocarcinoma. Pathol Res Pract 215(6):152394","journal-title":"Pathol Res Pract"},{"key":"11690_CR12","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.phrs.2020.105405","volume":"165","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yue M, Li Z (2021) FOSL1 promotes tumorigenesis in colorectal carcinoma by mediating the FBXL2\/Wnt\/\u03b2-catenin axis via Smurf1. Pharmacol Res 165:105405","journal-title":"Pharmacol Res"},{"key":"11690_CR13","doi-asserted-by":"publisher","first-page":"154496","DOI":"10.1016\/j.prp.2023.154496","volume":"246","author":"G Liu","year":"2023","unstructured":"Liu G et al (2023) FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cells. Pathol Res Pract 246:154496","journal-title":"Pathol Res Pract"},{"key":"11690_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020635","author":"S Shao","year":"2023","unstructured":"Shao S et al (2023) Influence of FOSL1 inhibition on vascular calcification and ROS generation through ferroptosis via P53-SLC7A11 axis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11020635","journal-title":"Biomedicines"},{"issue":"15","key":"11690_CR15","doi-asserted-by":"publisher","first-page":"7244","DOI":"10.1111\/jcmm.16753","volume":"25","author":"Z Chen","year":"2021","unstructured":"Chen Z et al (2021) CircPLCE1 facilitates the malignant progression of colorectal cancer by repressing the SRSF2-dependent PLCE1 pre-RNA splicing. J Cell Mol Med 25(15):7244\u20137256","journal-title":"J Cell Mol Med"},{"key":"11690_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043263","author":"L Liu","year":"2023","unstructured":"Liu L et al (2023) HBV enhances sorafenib resistance in hepatocellular carcinoma by reducing ferroptosis via SRSF2-mediated abnormal PCLAF splicing. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24043263","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11690_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mc.23647","volume":"63","author":"Y Xu","year":"2024","unstructured":"Xu Y et al (2024) Inhibition of the RBMS1\/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer. Mol Carcinog 63(2):224\u2013237","journal-title":"Mol Carcinog"},{"issue":"8","key":"11690_CR18","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41591-023-02497-z","volume":"29","author":"M Thibaudin","year":"2023","unstructured":"Thibaudin M et al (2023) First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b\/2 trial. Nat Med 29(8):2087\u20132098","journal-title":"Nat Med"},{"issue":"3","key":"11690_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/stmcls\/sxab024","volume":"40","author":"X He","year":"2022","unstructured":"He X et al (2022) ROR2 Downregulation Activates the MSX2\/NSUN2\/p21 Regulatory Axis and Promotes Dental Pulp Stem Cell Senescence. Stem Cells 40(3):290\u2013302","journal-title":"Stem Cells"},{"issue":"10","key":"11690_CR20","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.18632\/aging.202774","volume":"13","author":"C Yang","year":"2021","unstructured":"Yang C et al (2021) Suppressing the KIF20A\/NUAK1\/Nrf2\/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin. Aging 13(10):13515\u201313534","journal-title":"Aging"},{"issue":"28","key":"11690_CR21","doi-asserted-by":"publisher","first-page":"e2203357","DOI":"10.1002\/advs.202203357","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q et al (2022) Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer. Adv Sci (Weinh) 9(28):e2203357","journal-title":"Adv Sci (Weinh)"},{"key":"11690_CR22","doi-asserted-by":"publisher","first-page":"1417750","DOI":"10.3389\/fcell.2024.1417750","volume":"12","author":"J Xu","year":"2024","unstructured":"Xu J et al (2024) Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies. Front Cell Dev Biol 12:1417750","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"11690_CR23","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.ymthe.2021.03.024","volume":"29","author":"M Zhang","year":"2021","unstructured":"Zhang M et al (2021) FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Mol Ther 29(8):2583\u20132600","journal-title":"Mol Ther"},{"issue":"3","key":"11690_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11010-023-04737-9","volume":"479","author":"S Lin","year":"2024","unstructured":"Lin S, Zhu B (2024) Exosome-transmitted FOSL1 from cancer-associated fibroblasts drives colorectal cancer stemness and chemo-resistance through transcriptionally activating ITGB4. Mol Cell Biochem 479(3):665\u2013677","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"11690_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s13287-024-04083-7","volume":"15","author":"Q Qin","year":"2024","unstructured":"Qin Q et al (2024) FAM96B negatively regulates FOSL1 to modulate the osteogenic differentiation and regeneration of periodontal ligament stem cells via ferroptosis. Stem Cell Res Ther 15(1):471","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"11690_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2022.11.023","volume":"103","author":"L Cuarental","year":"2023","unstructured":"Cuarental L et al (2023) The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury. Kidney Int 103(4):686\u2013701","journal-title":"Kidney Int"},{"issue":"5\u20136","key":"11690_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1101\/gad.332270.119","volume":"34","author":"MA Rahman","year":"2020","unstructured":"Rahman MA et al (2020) Recurrent SRSF2 mutations in MDS affect both splicing and NMD. Genes Dev 34(5\u20136):413\u2013427","journal-title":"Genes Dev"},{"issue":"1","key":"11690_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2009.06.016","volume":"35","author":"XY Zhong","year":"2009","unstructured":"Zhong XY et al (2009) SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35(1):1\u201310","journal-title":"Mol Cell"},{"issue":"2","key":"11690_CR29","doi-asserted-by":"publisher","first-page":"102876","DOI":"10.1016\/j.jbc.2023.102876","volume":"299","author":"W Liu","year":"2023","unstructured":"Liu W et al (2023) Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma. J Biol Chem 299(2):102876","journal-title":"J Biol Chem"},{"issue":"11","key":"11690_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41419-023-06273-2","volume":"14","author":"SH Luo","year":"2023","unstructured":"Luo SH et al (2023) The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells. Cell Death Dis 14(11):760","journal-title":"Cell Death Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11690-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:37:56Z","timestamp":1774438676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11690-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11690"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11690-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"CRC tissue samples and matched adjacent cancerous tissues were collected from 27 patients who underwent surgical resection at Zhongshan City People\u2019s Hospital. Written informed consent was obtained, and this study was approved by the Ethics Committee of Zhongshan City People\u2019s Hospital (Approval Number: KY2024-345). All the procedures were performed in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"540"}}